Package 68180-292-07

Brand: eslicarbazepine acetate

Generic: eslicarbazepine acetate
NDC Package

Package Facts

Identity

Package NDC 68180-292-07
Digits Only 6818029207
Product NDC 68180-292
Product ID 68180-292_2c3d221b-f0d3-4845-8bbc-9a4df2f0cc33
Description

60 TABLET in 1 BOTTLE (68180-292-07)

Marketing

Marketing Status
Marketed Since 2025-05-06
Brand eslicarbazepine acetate
Generic eslicarbazepine acetate
Sample Package No

Linked Drug Pages (1)

Eslicarbazepine Acetate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2c3d221b-f0d3-4845-8bbc-9a4df2f0cc33", "openfda": {"upc": ["0368180290063", "0368180293064", "0368180292074"], "unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482515", "1482521", "1482525"], "spl_set_id": ["999b341f-fe13-4dd9-bb95-9b0d6a817c4c"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (68180-292-07)", "package_ndc": "68180-292-07", "marketing_start_date": "20250506"}], "brand_name": "Eslicarbazepine Acetate", "product_id": "68180-292_2c3d221b-f0d3-4845-8bbc-9a4df2f0cc33", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68180-292", "generic_name": "Eslicarbazepine Acetate", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eslicarbazepine Acetate", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "600 mg/1"}], "application_number": "ANDA211246", "marketing_category": "ANDA", "marketing_start_date": "20250506", "listing_expiration_date": "20261231"}